{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:48:45Z","timestamp":1741153725594,"version":"3.38.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The effect of acute and chronic treatments of the calcium-channel blockers, isradipine, diltiazem and flunarizine in protecting against lorazepam dependence has been demonstrated in mice.<\/jats:p><jats:p>Dependence was induced by twice-daily administration of lorazepam (1 mg kg\u22121) for 10 days, doubling the dose during the next 10 days. Withdrawal symptoms<\/jats:p><jats:p>and changes in the noradrenaline, dopamine and 5-hydroxytryptamine content of different regions of the brain were observed after either 24-h withdrawal or flumazenil administration. Isradipine inhibited lorazepam withdrawal symptoms, the effect being accompanied in the 24-h withdrawal group by significant decreases in the noradrenaline and dopamine content of the thalamus and hypothalamus and in the noradrenaline content of the mid-brain. In the flumazenil-treated group isradipine produced significant decreases in mid-brain noradrenaline and dopamine levels and in the dopamine content of the thalamus and hypothalamus. Diltiazem did not, on the other hand, afford significant protection against lorazepam withdrawal symptoms and did not induce any significant change in the neurotransmitters studied. Flunarizine significantly inhibited lorazepam withdrawal symptoms, an effect accompanied by significant reduction in noradrenaline and dopamine levels in the thalamus and hypothalamus. Dopamine was also significantly reduced in the cerebral cortex. Similar effects were produced in the flumazenil-treated group, and the noradrenaline content was reduced in the medulla, pons and cerebellum.<\/jats:p><jats:p>It was concluded that isradipine and flunarizine might be of value in ameliorating lorazepam withdrawal symptoms.<\/jats:p>","DOI":"10.1111\/j.2042-7158.1997.tb06805.x","type":"journal-article","created":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T04:44:20Z","timestamp":1302669860000},"page":"322-328","source":"Crossref","is-referenced-by-count":4,"title":["Influence of Certain Calcium-channel Blockers on Some Aspects of Lorazepam-dependence in Mice"],"prefix":"10.1093","volume":"49","author":[{"given":"Samir F","family":"Saad","sequence":"first","affiliation":[{"name":"Pharmacology Department, Faculty of Pharmacy, Cairo University , Cairo,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M T","family":"Khayyal","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Faculty of Pharmacy, Cairo University , Cairo,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina S","family":"Attia","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Faculty of Pharmacy, Cairo University , Cairo,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab S F","family":"Saad","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Faculty of Pharmacy, Cairo University , Cairo,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1997,3,1]]},"reference":[{"key":"2024103110234309500_cit1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1254\/jjp.41.431","article-title":"Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by calcium-channel blockers","volume":"41","author":"Adachi","year":"1986","journal-title":"Jpn J. Pharmacol."},{"key":"2024103110234309500_cit2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0028-3908(88)90016-0","article-title":"Increased central noradrenergic activity during benzodiazepine withdrawal: an electrophysiological study","volume":"27","author":"Bickford-Wimer","year":"1988","journal-title":"Neuropharmacology"},{"key":"2024103110234309500_cit3","first-page":"971","article-title":"Potential antiepileptic drugs; flunarizine and other calcium entry blockers","volume-title":"Antiepileptic Drugs","author":"Binnie","year":"1989","edition":"3rd edn"},{"key":"2024103110234309500_cit4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF00445563","article-title":"A comparison of calcium antagonists and diazepam in reducing ethanol tremors","volume":"99","author":"Bone","year":"1989","journal-title":"Psychopharmacology"},{"key":"2024103110234309500_cit5","first-page":"479","article-title":"Effectiveness of concurrently administered dihydropyridines in preventing the withdrawal syndrome from barbital","volume":"95","author":"Brown","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"2024103110234309500_cit6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0026-265X(78)90034-6","article-title":"Further modification of a fluorimetric method for analyzing brain amines","volume":"23","author":"Ciarlone","year":"1978","journal-title":"Microchem. J."},{"key":"2024103110234309500_cit7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bmj.4.5783.340","article-title":"Diazepam, alcohol and barbiturate abuse","volume":"4","author":"Clare","year":"1971","journal-title":"Br. Med. J."},{"key":"2024103110234309500_cit8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.2042-7158.1991.tb03559.x","article-title":"The effect of dihydropyridine calcium channel agents on 5-HT metabolism in the CNS of the rat","volume":"43","author":"Colado","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110234309500_cit9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0306-3623(93)90008-L","article-title":"Effect of nimodipine, diltiazem and Bay K 8644 on the behavioural and neurochemical changes associated with naloxone precipitated withdrawal in the rat","volume":"24","author":"Colado","year":"1993","journal-title":"Gen. Pharmacol."},{"key":"2024103110234309500_cit10","first-page":"1","article-title":"Benzodiazepines: dependence and withdrawal symptoms","volume":"21","year":"1988","journal-title":"Curr. Probl."},{"key":"2024103110234309500_cit11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF01972300","article-title":"Use of the specific benzodiazepine antagonist, Ro 15\u20131788, in studies of physiological dependence on benzodiazepines","volume":"38","author":"Cumin","year":"1982","journal-title":"Experientia"},{"key":"2024103110234309500_cit12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(92)90554-H","article-title":"Mechanism of blockade by flunarizine of bovine adrenal catecholamine release","volume":"229","author":"De La Fuente","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"2024103110234309500_cit13","first-page":"866","article-title":"Anticonvulsant profile and whole brain concentrations of nitrendipine and nimodipine","volume":"89","author":"Dolin","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"2024103110234309500_cit14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1476-5381.1990.tb14142.x","article-title":"Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs","volume":"101","author":"Dolin","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"2024103110234309500_cit15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01258630","article-title":"Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain","volume":"75","author":"Fadda","year":"1989","journal-title":"J. Neural Transm."},{"key":"2024103110234309500_cit16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1476-5381.1990.tb14167.x","article-title":"Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA receptor function","volume":"101","author":"Galpem","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"2024103110234309500_cit17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0002-9149(87)90077-4","article-title":"Classification of calcium antagonists","volume":"59","author":"Godfraind","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"2024103110234309500_cit18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(85)90680-8","article-title":"Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]nitrendipine","volume":"330","author":"Gould","year":"1985","journal-title":"Brain Res."},{"key":"2024103110234309500_cit19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/290514a0","article-title":"Selective antagonists of benzodiazepines","volume":"290","author":"Hunkeler","year":"1981","journal-title":"Nature"},{"key":"2024103110234309500_cit20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(87)90221-4","article-title":"Effect of certain benzodiazepines on brain dopamine content in experimental animals","volume":"137","author":"Ida","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"2024103110234309500_cit21","first-page":"249","article-title":"Effect of diazepam on stress-induced changes on brain noradrenaline","volume":"28","author":"Ida","year":"1988","journal-title":"Jpn J. Psychosom. Med."},{"key":"2024103110234309500_cit22","first-page":"399","article-title":"Neurochemical investigation on the effect of calcium antagonists on the striatal dopaminergic system on rats","volume":"58","author":"Ikegami","year":"1992","journal-title":"Jpn J. Pharmacol."},{"key":"2024103110234309500_cit23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.2042-7158.1991.tb03532.x","article-title":"Calcium antagonism by KB-2796, a new diphenylpiperazine analogue in dog vascular smooth muscle","volume":"43","author":"Iwamoto","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110234309500_cit24","first-page":"387","article-title":"Effect of dihydropyridine calcium channel antagonists in ethanol withdrawal","volume":"100","author":"Littleon","year":"1990","journal-title":"Psychopharmacol."},{"key":"2024103110234309500_cit25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(84)90218-8","article-title":"Precipitated diazepam withdrawal in baboons. Effects of dose and duration of diazepam exposure","volume":"100","author":"Lukas","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"2024103110234309500_cit26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0024-3205(84)90543-5","article-title":"Are dihydropyridine binding sites voltage-sensitive calcium channels?","volume":"43","author":"Miller","year":"1984","journal-title":"Life Sci."},{"key":"2024103110234309500_cit27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0024-3205(93)90211-K","article-title":"Effects of calcium-channel blockers on physical dependence on diazepam in mice","volume":"53","author":"Mizoguchi","year":"1993","journal-title":"Life Sci."},{"key":"2024103110234309500_cit28","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0024-3205(90)90115-8","article-title":"Antidopaminergic action of verapamil and several other drugs: inactivation of vesicular dopamine","volume":"46","author":"Nathan","year":"1990","journal-title":"Life Sci."},{"key":"2024103110234309500_cit29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004850-198704000-00009","article-title":"Benzodiazepines plasma MHPG and adrenoreceptor function in man","volume":"2","author":"Nutt","year":"1987","journal-title":"Int. J. Clin. Psychopharmacol."},{"key":"2024103110234309500_cit30","first-page":"161","volume-title":"Evaluation of drug activities. Pharmacometrics","author":"Paget","year":"1964"},{"key":"2024103110234309500_cit31","first-page":"81","article-title":"Benzodiazepine dependence","volume-title":"Tranquilizers: Social, Psychological and Clinical Perspectives","author":"Petursson","year":"1986"},{"key":"2024103110234309500_cit32","first-page":"43","article-title":"Some neurochemical correlates of 'rebound' phenomenon observed during withdrawal after long-term exposure to 1,4-benzodiazepine. Prog. Neuropsychopharmacol","volume":"2","author":"Rastogi","year":"1978","journal-title":"Biol. Psychiat."},{"key":"2024103110234309500_cit33","first-page":"165","article-title":"Comparative addictive liability of some benzodiazepines commonly used in Egypt in relation to changes in some central neurotransmitters in mice","volume":"19","author":"Saad","year":"1991","journal-title":"Med. Sci. Res."},{"key":"2024103110234309500_cit34","first-page":"465","article-title":"Changes in mouse brain aminobutyrate metabolism during lorazepam-induced abstinence syndromes","volume":"23","author":"Saad","year":"1995","journal-title":"Med. Sci. Res."},{"key":"2024103110234309500_cit35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJM198510173131606","article-title":"Calcium antagonist drugs: receptor interactions that clarify therapeutic effects","volume":"313","author":"Snyder","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"2024103110234309500_cit36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01249091","article-title":"The interaction of [3H]-PY 108\u2013068 and of [3H]-PN 200\u2013110 with calcium channel binding sites in the rat brain","volume":"60","author":"Supervialai","year":"1984","journal-title":"J. Neural Transm."},{"key":"2024103110234309500_cit37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0014-2999(69)90038-7","article-title":"The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of rat brain","volume":"8","author":"Taylor","year":"1969","journal-title":"Eur. J. Pharmacol."},{"key":"2024103110234309500_cit38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2007-1014578","article-title":"Benzodiazepine abuse and dependence in psychiatric patients","volume":"22","author":"Wolf","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"2024103110234309500_cit39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0031-6997(25)06658-X","article-title":"Abuse liability of benzodiazepines","volume":"39","author":"Woods","year":"1987","journal-title":"Pharmacol. Rev."},{"key":"2024103110234309500_cit40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3565(25)31226-7","article-title":"Effects of acute and chronic morphine treatments on calcium localization and binding in brain","volume":"205","author":"Yamamoto","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2024103110234309500_cit41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archpsyc.1988.01800260081011","article-title":"Serotonergic responsivity in obsessive compulsive disorder","volume":"45","author":"Zohar","year":"1988","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.1997.tb06805.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/49\/3\/322\/60267830\/j.2042-7158.1997.tb06805.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/49\/3\/322\/60267830\/j.2042-7158.1997.tb06805.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T01:28:54Z","timestamp":1741138134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/49\/3\/322\/6152944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3,1]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1997,3,1]]},"published-print":{"date-parts":[[1997,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.1997.tb06805.x","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"type":"electronic","value":"2042-7158"},{"type":"print","value":"0022-3573"}],"subject":[],"published-other":{"date-parts":[[1997,3]]},"published":{"date-parts":[[1997,3,1]]}}}